EC approves Santen’s Ryjunea to slow progression of paediatric myopia
5th June 2025 Uncategorised 0
Therapy indicated for children aged 3 to 14 at treatment initiation

More: EC approves Santen’s Ryjunea to slow progression of paediatric myopia
Source: News
